JPMorgan International Research Enhanced Equity ETF (JIRE)

NYSEARCA: JIRE · Real-Time Price · USD
75.48
-0.14 (-0.19%)
At close: Dec 5, 2025, 4:00 PM EST
75.53
+0.05 (0.07%)
After-hours: Dec 5, 2025, 8:00 PM EST
-0.19%
Assets $9.57B
Expense Ratio 0.24%
PE Ratio 16.47
Shares Out 127.03M
Dividend (ttm) $1.77
Dividend Yield 2.35%
Ex-Dividend Date Dec 24, 2024
Payout Ratio 38.64%
1-Year Return +20.25%
Volume 311,515
Open 75.81
Previous Close 75.62
Day's Range 75.40 - 75.89
52-Week Low 56.30
52-Week High 76.24
Beta 0.85
Holdings 220
Inception Date Jun 10, 2022

About JIRE

Fund Home Page

The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is issued by JPMorgan Chase.

Asset Class Equity
Category Foreign Large Blend
Region Global
Stock Exchange NYSEARCA
Ticker Symbol JIRE
ETF Provider JPMorgan Chase

Top 10 Holdings

16.57% of assets
Name Symbol Weight
ASML Holding N.V. ASML 2.69%
AstraZeneca PLC AZN 2.10%
Shell plc SHEL 1.79%
Siemens Aktiengesellschaft SIE 1.62%
Banco Santander, S.A. SAN 1.60%
Nestlé S.A. NESN 1.47%
Allianz SE ALV 1.44%
Safran SA SAF 1.32%
Roche Holding AG ROG 1.30%
UniCredit S.p.A. UCG 1.24%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 24, 2024 $1.77105 Dec 27, 2024
Dec 19, 2023 $1.59913 Dec 22, 2023
Dec 20, 2022 $1.31061 Dec 23, 2022
Full Dividend History

News

3 ETFs for Diversifying Beyond AI

Avoid paying for the high expectations for AI stocks with these ETFs. Why the AI Spending Spree Could Spell Trouble for Investors,

Other symbols: DFATFNDX
1 day ago - Morningstar

JIRE: A Reasonable International Bet In An Unsure Domestic Economy

JPMorgan International Research Enhanced Equity ETF launched as an ETF in June 2022 after operating as a mutual fund. JIRE invests in developed markets, with a focus on financials, industrials, health...

1 year ago - Seeking Alpha